The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Fc receptors in antibody‐dependent enhancement of viral infections
Open accessAbstract
Summary: Sensitization of the humoral immune response to invading viruses and production of antiviral antibodies forms part of the host antiviral repertoire. Paradoxically, for a number of viral pathogens, under certain conditions, antibodies provide an attractive means of enhanced virus entry and replication in a number of cell types. Known as antibody‐dependent enhancement (ADE) of infection, the phenomenon occurs when virus‐antibody immunocomplexes interact with cells bearing complement or Fc receptors, promoting internalization of the virus and increasing infection. Frequently associated with exacerbation of viral disease, ADE of infection presents a major obstacle to the prevention of viral disease by vaccination and is thought to be partly responsible for the adverse effects of novel antiviral therapeutics such as intravenous immunoglobulins. There is a growing body of work examining the intracellular signaling pathways and epitopes responsible for mediating ADE, with a view to aiding rational design of antiviral strategies. With in vitro studies also confirming ADE as a feature of infection for a growing number of viruses, challenges remain in understanding the multilayered molecular mechanisms of ADE and its effect on viral pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 1×
“DENV has a geographical distribution similar to CHIKV, causing massive worldwide outbreaks, with an estimated 390 million people suffering from DENV infections annually (21, 22).”
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
Simmons, C. P., Farrar, J. J., van Vinh Chau, N., & Wills, B. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110265 · Cited by 1,732
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
Imbach, P., d'APUZZO, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schöni, M., & Wagner, H. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92400-4 · Cited by 1,666
Bruhns, P., Iannascoli, B., England, P., Mancardi, D. A., Fernandez, N., Jorieux, S., & Daëron, M. (2009) · Blood · doi:10.1182/blood-2008-09-179754 · Cited by 1,479
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368
New World Bats Harbor Diverse Influenza A Viruses
Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003657 · Cited by 1,351
Guzman, M. G., & Harris, E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60572-9 · Cited by 1,345
Toll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,173
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Qiu, X., Wong, G., Audet, J., Bello, A., Fernando, L., Alimonti, J. B., Fausther-Bovendo, H., Wei, H., Aviles, J., Hiatt, E., et al. (2014) · Nature · doi:10.1038/nature13777 · Cited by 987
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889
Quasispecies Theory and the Behavior of RNA Viruses
Lauring, A. S., & Andino, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001005 · Cited by 846
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab, I., & Nimmerjahn, F. (2013) · Nature Reviews Immunology · doi:10.1038/nri3401 · Cited by 820
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804
West Nile Virus: Review of the Literature
Petersen, L. R., Brault, A. C., & Nasci, R. S. (2013) · JAMA · doi:10.1001/jama.2013.8042 · Cited by 769
Influenza: lessons from past pandemics, warnings from current incidents
Horimoto, T., & Kawaoka, Y. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1208 · Cited by 696
The function of Fcγ receptors in dendritic cells and macrophages
Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., & Lambrecht, B. N. (2014) · Nature Reviews Immunology · doi:10.1038/nri3582 · Cited by 639
Chikungunya: a re-emerging virus
Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S., & Heise, M. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60281-x · Cited by 638
Self-citationJensen, S., & Thomsen, A. R. (2012) · Journal of Virology · doi:10.1128/jvi.05738-11 · Cited by 604
Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages
Labadie, K., Larcher, T., Joubert, C., Mannioui, A., Delache, B., Brochard, P., Guigand, L., Dubreil, L., Lebon, P., Verrier, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40104 · Cited by 589
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Joller, N., Hafler, J. P., Brynedal, B., Kassam, N., Spoerl, S., Levin, S. D., Sharpe, A. H., & Kuchroo, V. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003081 · Cited by 581
Simmons, G., Reeves, J. D., Rennekamp, A. J., Amberg, S. M., Piefer, A. J., & Bates, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306446101 · Cited by 543
FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications
Smith, K. G. C., & Clatworthy, M. R. (2010) · Nature Reviews Immunology · doi:10.1038/nri2762 · Cited by 543
Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)
Mallery, D. L., McEwan, W. A., Bidgood, S. R., Towers, G. J., Johnson, C. M., & James, L. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014074107 · Cited by 516
Arthritogenic alphaviruses—an overview
Suhrbier, A., Jaffar-Bandjee, M.-C., & Gasque, P. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.64 · Cited by 489
West Nile virus infection and immunity
Suthar, M. S., Diamond, M. S., & Gale Jr, M. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2950 · Cited by 430
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Wang, S.-F., Tseng, S.-P., Yen, C.-H., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F.-T., Liu, W.-T., Chen, Y.-M. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 415
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Balsitis, S. J., Williams, K. L., Lachica, R., Flores, D., Kyle, J. L., Mehlhop, E., Johnson, S., Diamond, M. S., Beatty, P. R., & Harris, E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000790 · Cited by 412
CLEC5A is critical for dengue-virus-induced lethal disease
Chen, S.-T., Lin, Y.-L., Huang, M.-T., Wu, M.-F., Cheng, S.-C., Lei, H.-Y., Lee, C.-K., Chiou, T.-W., Wong, C.-H., & Hsieh, S.-L. (2008) · Nature · doi:10.1038/nature07013 · Cited by 411
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Self-citationA Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Regules, J. A., Beigel, J. H., Paolino, K. M., Voell, J., Castellano, A. R., Hu, Z., Muñoz, P., Moon, J. E., Ruck, R. C., Bennett, J. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1414216 · Cited by 387
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Getts, D. R., Terry, R. L., Getts, M. T., Deffrasnes, C., Müller, M., van Vreden, C., Ashhurst, T. M., Chami, B., McCarthy, D., Wu, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007563 · Cited by 378
Self-citationActivating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
Boruchov, A. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24772 · Cited by 377
The ferret as a model organism to study influenza A virus infection
Belser, J. A., Katz, J. M., & Tumpey, T. M. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007823 · Cited by 364
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond
Hogarth, P. M., & Pietersz, G. A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2909 · Cited by 348
Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans
Malik Peiris, J. S., Poon, L. L. M., & Guan, Y. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.06.006 · Cited by 346
Zellweger, R. M., Prestwood, T. R., & Shresta, S. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.004 · Cited by 338
Jiang, D., Weidner, J. M., Qing, M., Pan, X.-B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P.-Y., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02199-09 · Cited by 337
Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications
Takada, A., & Kawaoka, Y. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.405 · Cited by 332
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
Kortepeter, M. G., Bausch, D. G., & Bray, M. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir299 · Cited by 328
Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., Wu, H.-C., Chang, G.-J., & Wang, W.-K. (2008) · Journal of Virology · doi:10.1128/jvi.00316-08 · Cited by 326
Fried, J. R., Gibbons, R. V., Kalayanarooj, S., Thomas, S. J., Srikiatkhachorn, A., Yoon, I.-K., Jarman, R. G., Green, S., Rothman, A. L., & Cummings, D. A. T. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000617 · Cited by 322
RIG-I, MDA5 and TLR3 Synergistically Play an Important Role in Restriction of Dengue Virus Infection
Nasirudeen, A. M. A., Wong, H. H., Thien, P., Xu, S., Lam, K.-P., & Liu, D. X. (2011) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000926 · Cited by 318
Jaume, M., Yip, M. S., Cheung, C. Y., Leung, H. L., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 314
Self-citationThe Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Smith, P., DiLillo, D. J., Bournazos, S., Li, F., & Ravetch, J. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203954109 · Cited by 307
Skowronski, D. M., De Serres, G., Crowcroft, N. S., Janjua, N. Z., Boulianne, N., Hottes, T. S., Rosella, L. C., Dickinson, J. A., Gilca, R., Sethi, P., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000258 · Cited by 297
Occupancy and mechanism in antibody-mediated neutralization of animal viruses
Klasse, P. J., & Sattentau, Q. J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2091 · Cited by 287
Primary immunodeficiency disorders: Antibody deficiency
Ballow, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122466 · Cited by 277
Wahala, W. M. P. B., Kraus, A. A., Haymore, L. B., Accavitti-Loper, M. A., & de Silva, A. M. (2009) · Virology · doi:10.1016/j.virol.2009.06.037 · Cited by 274
Manimunda, S. P., Vijayachari, P., Uppoor, R., Sugunan, A. P., Singh, S. S., Rai, S. K., Sudeep, A. B., Muruganandam, N., Chaitanya, I. K., & Guruprasad, D. R. (2010) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2010.01.011 · Cited by 274
Immature Dengue Virus: A Veiled Pathogen?
Rodenhuis-Zybert, I. A., van der Schaar, H. M., da Silva Voorham, J. M., van der Ende-Metselaar, H., Lei, H.-Y., Wilschut, J., & Smit, J. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000718 · Cited by 268
Lowell, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002352 · Cited by 266
Ballow, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 253
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Yip, M. S., Leung, N. H. L., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, J. S. M., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 250
Self-citationToxicity after prolonged (more than four weeks) administration of intravenous colistin
Falagas, M. E., Rizos, M., Bliziotis, I. A., Rellos, K., Kasiakou, S. K., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-1 · Cited by 242
Chareonsirisuthigul, T., Kalayanarooj, S., & Ubol, S. (2007) · Journal of General Virology · doi:10.1099/vir.0.82537-0 · Cited by 238
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks
Guzmán, M. G., Kourí, G., Valdés, L., Bravo, J., Vázquez, S., & Halstead, S. B. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002000400003 · Cited by 234
Khurana, S., Loving, C. L., Manischewitz, J., King, L. R., Gauger, P. C., Henningson, J., Vincent, A. L., & Golding, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006366 · Cited by 223
Avian Influenza in Hong Kong 1997–2002
Sims, L. D., Ellis, T. M., Liu, K. K., Dyrting, K., Wong, H., Peiris, M., Guan, Y., & Shortridge, K. F. (2003) · Avian Diseases · doi:10.1637/0005-2086-47.s3.832 · Cited by 223
Kam, Y. W., Kien, F., Roberts, A., Cheung, Y. C., Lamirande, E. W., Vogel, L., Chu, S. L., Tse, J., Guarner, J., Zaki, S. R., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.011 · Cited by 210
CLEC5A is critical for dengue virus–induced inflammasome activation in human macrophages
Wu, M.-F., Chen, S.-T., Yang, A.-H., Lin, W.-W., Lin, Y.-L., Chen, N.-J., Tsai, I.-S., Li, L., & Hsieh, S.-L. (2013) · Blood · doi:10.1182/blood-2012-05-430090 · Cited by 210
Shrestha, B., Brien, J. D., Sukupolvi-Petty, S., Austin, S. K., Edeling, M. A., Kim, T., O'Brien, K. M., Nelson, C. A., Johnson, S., Fremont, D. H., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000823 · Cited by 208
Antibody-Dependent Enhancement of Ebola Virus Infection
Takada, A., Feldmann, H., Ksiazek, T. G., & Kawaoka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7539-7544.2003 · Cited by 206
Human TLR3 recognizes dengue virus and modulates viral replication in vitro
Tsai, Y.-T., Chang, S.-Y., Lee, C.-N., & Kao, C.-L. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01277.x · Cited by 203
Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Überla, K., Niedrig, M., & Pöhlmann, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6134-6142.2004 · Cited by 199
Maternal Antibody and Viral Factors in the Pathogenesis of Dengue Virus in Infants
Simmons, C. P., Chau, T. N. B., Thuy, T. T., Tuan, N. M., Hoang, D. M., Thien, N. T., Lien, L. B., Quy, N. T., Hieu, N. T., Hien, T. T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/519170 · Cited by 198
Ubol, S., Phuklia, W., Kalayanarooj, S., & Modhiran, N. (2010) · The Journal of Infectious Diseases · doi:10.1086/651018 · Cited by 196
de Alwis, R., Williams, K. L., Schmid, M. A., Lai, C.-Y., Patel, B., Smith, S. A., Crowe, J. E., Wang, W.-K., Harris, E., & de Silva, A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004386 · Cited by 194
Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in mice
Webster, R. G., & Askonas, B. A. (1980) · European Journal of Immunology · doi:10.1002/eji.1830100515 · Cited by 192
Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection
Boonnak, K., Slike, B. M., Burgess, T. H., Mason, R. M., Wu, S.-J., Sun, P., Porter, K., Rudiman, I. F., Yuwono, D., Puthavathana, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02484-07 · Cited by 191
Chau, T. N. B., Quyen, N. T. H., Thuy, T. T., Tuan, N. M., Hoang, D. M., Dung, N. T. P., Lien, L. B., Quy, N. T., Hieu, N. T., Hieu, L. T. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590117 · Cited by 186
Zhang, L., Zhang, F., Yu, W., He, T., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 186
Engle, M. J., & Diamond, M. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.12941-12949.2003 · Cited by 180
Olsen, C. W., Corapi, W. V., Ngichabe, C. K., Baines, J. D., & Scott, F. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.956-965.1992 · Cited by 179
Vogelpoel, L. T. C., Hansen, I. S., Rispens, T., Muller, F. J. M., van Capel, T. M. M., Turina, M. C., Vos, J. B., Baeten, D. L. P., Kapsenberg, M. L., de Jong, E. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6444 · Cited by 175
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
Nelson, S., Jost, C. A., Xu, Q., Ess, J., Martin, J. E., Oliphant, T., Whitehead, S. S., Durbin, A. P., Graham, B. S., Diamond, M., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000060 · Cited by 173
Vaccine-induced enhancement of viral infections
Huisman, W., Martina, B. E. E., Rimmelzwaan, G. F., Gruters, R. A., & Osterhaus, A. D. M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.10.087 · Cited by 172
Immunopathogenesis of vaccine-enhanced RSV disease
Openshaw, P. J. M., Culley, F. J., & Olszewska, W. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00301-2 · Cited by 172
RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets
Knudson, C. J., Hartwig, S. M., Meyerholz, D. K., & Varga, S. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004757 · Cited by 171
Libraty, D. H., Acosta, L. P., Tallo, V., Segubre-Mercado, E., Bautista, A., Potts, J. A., Jarman, R. G., Yoon, I.-K., Gibbons, R. V., Brion, J. D., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000171 · Cited by 171
Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., & Akira, S. (2009) · Nature Immunology · doi:10.1038/ni.1771 · Cited by 168
Regulation of Toll‐like receptor signaling pathways in innate immune responses
Qian, C., & Cao, X. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06786.x · Cited by 167
Vogelpoel, L. T. C., Baeten, D., de Jong, E. C., & den Dunnen, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00079 · Cited by 165
Miner, J. J., Aw Yeang, H. X., Fox, J. M., Taffner, S., Malkova, O. N., Oh, S. T., Kim, A. H. J., Diamond, M. S., Lenschow, D. J., & Yokoyama, W. M. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39027 · Cited by 163
New Insights in the Immunobiology of IL-1 Family Members
van de Veerdonk, F. L., & Netea, M. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00167 · Cited by 163
ALVAREZ, M., RODRIGUEZ-ROCHE, R., BERNARDO, L., VÁZQUEZ, S., MORIER, L., GONZALEZ, D., CASTRO, O., KOURI, G., HALSTEAD, S. B., & GUZMAN, M. G. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.1113 · Cited by 162
Immunological enhancement of dengue virus replication.
Halstead, S. B., Chow, J. S., & Marchette, N. J. (1973) · PubMed · Cited by 162
Smith, S. A., Zhou, Y., Olivarez, N. P., Broadwater, A. H., de Silva, A. M., & Crowe, J. E. (2012) · Journal of Virology · doi:10.1128/jvi.06335-11 · Cited by 161
Host response to influenza virus: protection versus immunopathology
Peiris, J., Hui, K. P., & Yen, H.-L. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.06.003 · Cited by 160
Lidbury, B. A., Rulli, N. E., Suhrbier, A., Smith, P. N., McColl, S. R., Cunningham, A. L., Tarkowski, A., van Rooijen, N., Fraser, R. J., & Mahalingam, S. (2008) · The Journal of Infectious Diseases · doi:10.1086/587841 · Cited by 152
Self-citationRodríguez-Madoz, J. R., Belicha‐Villanueva, A., Bernal‐Rubio, D., Ashour, J., Ayllón, J., & Fernández-Sesma, A. (2010) · Journal of Virology · doi:10.1128/jvi.01051-10 · Cited by 150
Dowd, K. A., Jost, C. A., Durbin, A. P., Whitehead, S. S., & Pierson, T. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002111 · Cited by 149
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
Nagelkerke, S. Q., & Kuijpers, T. W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00674 · Cited by 149
Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection
Chan, K. R., Zhang, S. L.-X., Tan, H. C., Chan, Y., Chow, A. Y., Lim, A. P. C., Vasudevan, S. G., Hanson, B. J., & Ooi, E. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106568108 · Cited by 148
Sindbis viruses and other alphaviruses as cause of human arthritic disease
Laine, M., Luukkainen, R., & Toivanen, A. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01413.x · Cited by 147
Rulli, N. E., Rolph, M. S., Srikiatkhachorn, A., Anantapreecha, S., Guglielmotti, A., & Mahalingam, S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir470 · Cited by 147
Self-citationDhodapkar, K. M., Banerjee, D. K., Connolly, J., Kukreja, A., Matayeva, E., Veri, M. C., Ravetch, J. V., Steinman, R. M., & Dhodapkar, M. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062545 · Cited by 141
Campbell, I. K., Miescher, S., Branch, D. R., Mott, P. J., Lazarus, A. H., Han, D., Maraskovsky, E., Zuercher, A. W., Neschadim, A., Leontyev, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301611 · Cited by 140
Neutralizing Antibody Response and SARS Severity
Ho, M., Chen, W., Chen, H., Lin, S.-F., Wang, M.-C., Di, J., Lu, Y., Liu, C., Chang, S., Chao, C.-L., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.040659 · Cited by 138
Chen, W., Foo, S., Taylor, A., Lulla, A., Merits, A., Hueston, L., Forwood, M. R., Walsh, N. C., Sims, N. A., Herrero, L. J., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02034-14 · Cited by 137
Self-citationClark, K., Takeuchi, O., Akira, S., & Cohen, P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114194108 · Cited by 135
Marzi, A., Yoshida, R., Miyamoto, H., Ishijima, M., Suzuki, Y., Higuchi, M., Matsuyama, Y., Igarashi, M., Nakayama, E., Kuroda, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036192 · Cited by 135
Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss
Chen, W., Foo, S., Rulli, N. E., Taylor, A., Sheng, K., Herrero, L. J., Herring, B. L., Lidbury, B. A., Li, R., Walsh, N. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318859111 · Cited by 133
Self-citationde Swart, R. L., Kuiken, T., Timmerman, H. H., van Amerongen, G., van den Hoogen, B. G., Vos, H. W., Neijens, H. J., Andeweg, A. C., & Osterhaus, A. D. M. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11561-11569.2002 · Cited by 133
Boonnak, K., Dambach, K. M., Donofrio, G. C., Tassaneetrithep, B., & Marovich, M. (2010) · Journal of Virology · doi:10.1128/jvi.00220-10 · Cited by 131
Chanas, A. C., Gould, E. A., Clegg, J. C. S., et al. (1982) · Journal of General Virology · doi:10.1099/0022-1317-58-1-37 · Cited by 129
Robinson, W. E., Kawamura, T., Górny, M. K., Lake, D. F., Xu, J. Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, W. M., & Hersh, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3185 · Cited by 122
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue
Chan, K. R., Ong, E. Z., Tan, H. C., Zhang, S. L.-X., Zhang, Q., Tang, K. F., Kaliaperumal, N., Lim, A. P. C., Hibberd, M. L., Chan, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317454111 · Cited by 120
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
Lee, N. L. S., Chan, P. K. S., Ip, M., Wong, E., Ho, J., Ho, C., Cockram, C. S., & Hui, D. S. C. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2005.07.005 · Cited by 119
Guillain-Barré Syndrome after Chikungunya Infection
Lebrun, G., Chadda, K., Reboux, A.-H., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1503.071482 · Cited by 117
Perez, A. B., Sierra, B., García, G., Aguirre, E., Babel, N., Álvarez, M., Sanchez, L., Valdés, L., Volk, H., & Guzmán, M. G. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.08.004 · Cited by 116
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein
Takada, A., Watanabe, S., Okazaki, K., Kida, H., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2324-2330.2001 · Cited by 116
Prestwood, T. R., Morar, M. M., Zellweger, R. M., Miller, R., May, M. M., Yauch, L. E., Lada, S. M., & Shresta, S. (2012) · Journal of Virology · doi:10.1128/jvi.06743-11 · Cited by 114
We, R., Montefiori, D. C., Dh, G., & Wm, M. (1989) · PubMed · Cited by 111
Neves-Souza, P. C., de Azeredo, E. L., Zagne, S. M., de Souza, R. V., Reis, S. R. N. I., Cerqueira, D. I., Nogueira, R. M., & Kubelka, C. F. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-64 · Cited by 109
Chikungunya at the Door — Déjà Vu All Over Again?
Morens, D. M., & Fauci, A. S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1408509 · Cited by 106
Chikungunya outbreak in Réunion: epidemiology and surveillance, 2005 to early January 2006
Paquet, C., Quatresous, I., Solet, J.-L., et al. (2006) · Weekly releases (1997–2007) · doi:10.2807/esw.11.05.02891-en · Cited by 106
Modhiran, N., Kalayanarooj, S., & Ubol, S. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000924 · Cited by 105
Ng, J. K. W., Zhang, S. L.-X., Tan, H. C., Yan, B., Gómez, J. M. M., Tan, W. Y., Lam, J. H., Tan, G. K. X., Ooi, E. E., & Alonso, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004031 · Cited by 103
Ben‐Nathan, D., Gershoni‐Yahalom, O., Samina, I., Khinich, Y., Nur, I., Laub, O., Gottreich, A., Simanov, M., Porgador, A., Rager‐Zisman, B., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-18 · Cited by 103
Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor
Yang, Z., & Björkman, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804551105 · Cited by 102
Mahalingam, S., & Lidbury, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202415999 · Cited by 101
Self-citationCrum‐Cianflone, N. F., Blair, P. J., Faix, D. J., Arnold, J. C., Echols, S., Sherman, S. S., Tueller, J. E., Warkentien, T. E., Sanguineti, G., Bavaro, M. F., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/648508 · Cited by 101
Lidbury, B. A., & Mahalingam, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8376-8381.2000 · Cited by 100
Self-citationAssociation of dengue virus NS1 protein with lipid rafts
Noisakran, S., Dechtawewat, T., Avirutnan, P., Kinoshita, T., Siripanyaphinyo, U., Puttikhunt, C., Kasinrerk, W., Malasit, P., & Sittisombut, N. (2008) · Journal of General Virology · doi:10.1099/vir.0.83620-0 · Cited by 99
The enhancement of virus infectivity by antibody
Hawkes, R. A., & Lafferty, K. J. (1967) · Virology · doi:10.1016/0042-6822(67)90144-4 · Cited by 99
SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients
Li, L., Wo, J.-E., Shao, J., Zhu, H., Wu, N., Li, M., Hangpin, Y., Hu, M., & Dennin, R. H. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(03)00195-1 · Cited by 98
GSK3: an in-Toll-erant protein kinase?
Woodgett, J. R., & Ohashi, P. S. (2005) · Nature Immunology · doi:10.1038/ni0805-751 · Cited by 97
Arthritogenic alphaviruses: new insights into arthritis and bone pathology
Chen, W., Foo, S., Sims, N. A., Herrero, L. J., Walsh, N. C., & Mahalingam, S. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.005 · Cited by 97
Self-citationGetts, D. R., Terry, R. L., Getts, M. T., Müller, M., Rana, S., Deffrasnes, C., Ashhurst, T. M., Radford, J., Hofer, M., Thomas, S., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-246 · Cited by 95
Self-citationvon Kietzell, K., Pozzuto, T., Heilbronn, R., Größl, T., Fechner, H., & Weger, S. (2014) · Journal of Virology · doi:10.1128/jvi.00649-14 · Cited by 95
Liang, Z., Wu, S., Li, Y., Li, H., Wu, M., Jiang, L., Feng, L., Zhang, P., & Huang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023346 · Cited by 94
Soundravally, R., Hoti, S. L., Patil, S. A., Cherupanakkal, C., Bobby, Z., Kadhiravan, T., Parameswaran, N., & Kumar, B. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.022 · Cited by 92
Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus
Kostyuchenko, V. A., Chew, P. L., Ng, T., & Lok, S. (2013) · Journal of Virology · doi:10.1128/jvi.02641-13 · Cited by 92
Gonzalez, D. C., Castro, O., Kourí, G., Pérez, J., Martinez, E., Vázquez, S., Rosario, D., Cancio, R., & Guzmán, M. G. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.012 · Cited by 90
An Ebola whole-virus vaccine is protective in nonhuman primates
Marzi, A., Halfmann, P., Hill-Batorski, L., Feldmann, F., Shupert, W. L., Neumann, G., Feldmann, H., & Kawaoka, Y. (2015) · Science · doi:10.1126/science.aaa4919 · Cited by 90
ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro
Dai, J., Pan, W., & Wang, P. (2011) · Virology Journal · doi:10.1186/1743-422x-8-468 · Cited by 90
Midgley, C. M., Flanagan, A., Tran, H. B., Dejnirattisai, W., Chawansuntati, K., Jumnainsong, A., Wongwiwat, W., Duangchinda, T., Mongkolsapaya, J., Grimes, J. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200227 · Cited by 90
The yin-yang of long pentraxin PTX3 in inflammation and immunity
Daigo, K., Mantovani, A., & Bottazzi, B. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.04.012 · Cited by 89
West Nile Virus Neutralization by US Plasma–Derived Immunoglobulin Products
Planitzer, C. B., Modrof, J., & Kreil, T. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/519392 · Cited by 88
An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection
Tsai, T., Chuang, Y.-J., Lin, Y.-S., Wan, S.-W., Chen, C., & Lin, C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-40 · Cited by 87
Smith, S. A., de Alwis, R., Kose, N., Durbin, A. P., Whitehead, S. S., de Silva, A. M., & Crowe, J. E. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit119 · Cited by 87
den Dunnen, J., Vogelpoel, L. T. C., Wypych, T. P., Muller, F. J. M., de Boer, L., Kuijpers, T. W., Zaat, S. A. J., Kapsenberg, M. L., & de Jong, E. C. (2012) · Blood · doi:10.1182/blood-2011-12-399931 · Cited by 86
Hohdatsu, T., Nakamura, M., Ishizuka, Y., Yamada, H., & Koyama, H. (1991) · Archives of Virology · doi:10.1007/bf01310476 · Cited by 86
Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
Richardson, J. S., Yao, M. N. K., Tran, K. N., Croyle, M. A., Strong, J. E., Feldmann, H., & Kobinger, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005308 · Cited by 86
Moss, W. J., Scott, S., Mugala, N., Ndhlovu, Z. M., Beeler, J. A., Audet, S. A., Ngala, M., Mwangala, S., Nkonga‐Mwangilwa, C., Ryon, J. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/519169 · Cited by 85
Tsai, C.-Y., Liong, K. H., Gunalan, M. G., Li, N., Lim, D. S. L., Fisher, D. A., MacAry, P. A., Leo, Y., Wong, S. C., Puan, K. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1303343 · Cited by 85
Dengue Virus Subverts the Interferon Induction Pathway via NS2B/3 Protease-IκB Kinase ε Interaction
Angleró-Rodríguez, Y., Pantoja, P., & Sariol, C. A. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00500-13 · Cited by 83
Case Reports of Neuro-Chikungunya in Southern Thailand
Chusri, S., Siripaitoon, P., Hirunpat, S., & Silpapojakul, K. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0725 · Cited by 80
Antibody-Mediated Enhancement of Viral Disease
Sullivan, N. J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_8 · Cited by 79
C1q—how many functions? How many receptors?
Eggleton, P. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01373-7 · Cited by 79
Human FcγRII Cytoplasmic Domains Differentially Influence Antibody-Mediated Dengue Virus Infection
Boonnak, K., Slike, B. M., Donofrio, G. C., & Marovich, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203052 · Cited by 78
Sariol, C. A., Martínez, M. I., Rivera, F., Rodríguez, I. V., Pantoja, P., Abel, K., Arana, T., Giavedoni, L. D., Hodara, V. L., White, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019323 · Cited by 74
Prime-Boost Immunization Strategies against Chikungunya Virus
Hallengärd, D., Lum, F., Kümmerer, B. M., Lulla, A., Lulla, V., García‐Arriaza, J., Fazakerley, J. K., Roques, P., Grand, R. L., Merits, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01926-14 · Cited by 74
Watanabe, S., Chan, K. W. K., Wang, J., Rivino, L., Lok, S., & Vasudevan, S. G. (2015) · Journal of Virology · doi:10.1128/jvi.00216-15 · Cited by 73
Kou, Z., Lim, J. Y. H., Beltramello, M., Quinn, M., Chen, H., Liu, S.-N., Martínez‐Sobrido, L., Diamond, M., Schlesinger, J. J., de Silva, A., et al. (2010) · Virology · doi:10.1016/j.virol.2010.11.007 · Cited by 72
Tsai, T.-T., Chuang, Y.-J., Lin, Y.-S., Chang, C., Wan, S.-W., Lin, S. H., Chen, C.-L., & Lin, C. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003320 · Cited by 71
Clinical and Virological Features of Dengue in Vietnamese Infants
Chau, T. N. B., Anders, K. L., Lien, L. B., Hùng, N. T., Hieu, L. T. M., Tuan, N. M., Thuy, T. T. D., Phuong, L. T., Thắm, N. T., Lanh, M. N., et al. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000657 · Cited by 71
Cowling, B. J., Ng, S., Ma, E. S. K., Fang, V. J., So, H. C., Wai, W., Cheng, C. K. Y., Wong, J. Y., Chan, K., Ip, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis518 · Cited by 70
Krilov, L. R., Anderson, L. J., Marcoux, L., Bonagura, V. R., & Wedgwood, J. F. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.5.777 · Cited by 69
de Swart, R. L., van den Hoogen, B. G., Kuiken, T., Herfst, S., van Amerongen, G., Yüksel, S., Sprong, L., & Osterhaus, A. D. M. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.022 · Cited by 67
Fcγ Receptor IIb Strongly Regulates Fcγ Receptor-Facilitated T Cell Activation by Dendritic Cells
van Montfoort, N., Hoen, P. A. C. ’., Mangsbo, S. M., Camps, M. G. M., Boross, P., Melief, C. J. M., OSSENDORP, F. A., & Verbeek, J. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103703 · Cited by 67
Torres, S., Hernández, J. C., Giraldo, D. M., Arboleda, M., Rojas, M., Smit, J. M., & Inchima, S. U. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002060 · Cited by 66
Perinatal Transmission of Dengue: A Report of 7 Cases
Ribeiro, C. F., Lopes, V. G. S., Brasil, P., Coelho, J., Muniz, A. G., & Nogueira, R. M. R. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.06.040 · Cited by 66
Daigo, K., & Hamakubo, T. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00378 · Cited by 64
Antibody-Dependent Enhancement of Marburg Virus Infection
Nakayama, E., Tomabechi, D., Matsuno, K., Kishida, N., Yoshida, R., Feldmann, H., & Takada, A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir334 · Cited by 63
Kobinger, G. P., Meunier, I., Patel, A. R., Pillet, S., Gren, J., Stebner, S., Leung, A., Neufeld, J., Kobasa, D., & von Messling, V. (2010) · The Journal of Infectious Diseases · doi:10.1086/651171 · Cited by 63
Bánki, Z., Kacani, L., Müllauer, B., Wilflingseder, D., Obermoser, G., Niederegger, H., Schennach, H., Sprinzl, G. M., Sepp, N. T., Erdei, A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3963 · Cited by 61
Assunção‐Miranda, I., Bozza, M. T., & Poian, A. T. D. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21649 · Cited by 61
Dai, X., Jayapal, M., Tay, H. K., Reghunathan, R., Lin, G., Too, C. T., Lim, Y. T., Chan, S. H., Kemeny, D. M., Floto, R. A., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184457 · Cited by 61
Ochiai, H., Kurokawa, M., Matsui, S., Yamamoto, T., Kuroki, Y., Kishimoto, C., & Shiraki, K. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890360312 · Cited by 61
Monomeric IgG in Intravenous Ig Preparations Is a Functional Antagonist of FcγRII and FcγRIIIb
van Mirre, E., Teeling, J. L., van der Meer, J. W. M., Bleeker, W. K., & Hack, C. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.332 · Cited by 58
Morens, D. M., Venkateshan, C. N. S., & Halstead, S. B. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-1-91 · Cited by 57
In vitro Enhancement of Respiratory Syncytial Virus Infection of U937 Cells by Human Sera
Gimenez, H. B., Keir, H. M., & Cash, P. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-89 · Cited by 54
Moi, M. L., Lim, C., Kotaki, A., Takasaki, T., & Kurane, I. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir053 · Cited by 52
Puerta-Guardo, H. N., Raya‐Sandino, A., González‐Mariscal, L., Rosales, V. H., Ayala-Dávila, J., Chávez‐Munguía, B., Martínez‐Fong, D., Medina, F., Ludert, J. E., & del Angel, R. M. (2013) · Journal of Virology · doi:10.1128/jvi.00085-13 · Cited by 51
Morrison, J. M., Josset, L., Tchitchek, N., Chang, J., Belser, J. A., Swayne, D. E., Pantin‐Jackwood, M. J., Tumpey, T. M., & Katze, M. G. (2014) · Journal of Virology · doi:10.1128/jvi.00570-14 · Cited by 48
Lamar, D. L., Weyand, C. M., & Goronzy, J. J. (2010) · Blood · doi:10.1182/blood-2009-09-243493 · Cited by 45
Srivastava, R., Ramakrishna, C., & Cantin, E. M. (2015) · Journal of General Virology · doi:10.1099/vir.0.000079 · Cited by 40
Antiviral effect of nitric oxide during Japanese encephalitis virus infection
Saxena, S. K., Singh, A., & Mathur, A. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00148.x · Cited by 39
Down-Regulation of Mast Cell Responses through ITIM Containing Inhibitory Receptors
Karra, L., & Levi‐Schaffer, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9533-9_9 · Cited by 38
Foo, S., Chen, W., Taylor, A., Sheng, K., Yu, X., Teng, T., Reading, P. C., Blanchard, H., Garlanda, C., Mantovani, A., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004649 · Cited by 37
Self-citationThe emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection
Lichterfeld, M. D., & Yu, X. G. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811442 · Cited by 37
Schultz, H. S., Nitze, L. M., Zeuthen, L., Keller, P., Gruhler, A., Pass, J., Chen, J., Guo, L., Fleetwood, A. J., Hamilton, J. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402800 · Cited by 36
Cited by
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., Chen, R. E., Carter, L., Walls, A. C., Park, Y.-J., et al. (2020) · Science · doi:10.1126/science.abd9909 · Cited by 742
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 572
Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., Zost, S. J., Jang, H., Huang, Y., Allen, J. D., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.026 · Cited by 366
Muralidar, S., Ambi, S. V., Sekaran, S., & Krishnan, U. M. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.018 · Cited by 346
Metadata
- Authors
- Taylor, A., Foo, S., Bruzzone, R., Vu Dinh, L., King, N. J. C., & Mahalingam, S.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-10-26
- Volume
- 268
- Issue
- 1
- Pages
- 340-364
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2102144534
- Cited by
- 255
- References
- 216
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.